Detalhe da pesquisa
1.
Transcranial direct current stimulation effects on neural processing in post-stroke aphasia.
Hum Brain Mapp
; 38(3): 1518-1531, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27859982
2.
Characterization of residual ß cell function in long-standing type 1 diabetes.
Diabetes Metab Res Rev
; 30(2): 154-62, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24115337
3.
Co-Occurring Alterations in Multiple Tumor Suppressor Genes Are Associated With Worse Outcomes in Patients With EGFR-Mutant Lung Cancer.
J Thorac Oncol
; 19(2): 240-251, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37806385
4.
ASCL1 Drives Tolerance to Osimertinib in EGFR Mutant Lung Cancer in Permissive Cellular Contexts.
Cancer Res
; 84(8): 1303-1319, 2024 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38359163
5.
Efficacy of Osimertinib in Patients with Lung Cancer Positive for Uncommon EGFR Exon 19 Deletion Mutations.
Clin Cancer Res
; 29(11): 2123-2130, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36913537
6.
Mammalian SWI/SNF chromatin remodeling complexes promote tyrosine kinase inhibitor resistance in EGFR-mutant lung cancer.
Cancer Cell
; 41(8): 1516-1534.e9, 2023 08 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37541244
7.
Genetic Determinants of EGFR-Driven Lung Cancer Growth and Therapeutic Response In Vivo.
Cancer Discov
; 11(7): 1736-1753, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33707235
8.
The EGFR Exon 19 Mutant L747-A750>P Exhibits Distinct Sensitivity to Tyrosine Kinase Inhibitors in Lung Adenocarcinoma.
Clin Cancer Res
; 25(21): 6382-6391, 2019 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31182434
9.
EGFR-Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical Outcomes.
J Clin Oncol
; 37(4): 278-285, 2019 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30550363
10.
Clinical Features and Management of Acquired Resistance to PD-1 Axis Inhibitors in 26 Patients With Advanced Non-Small Cell Lung Cancer.
J Thorac Oncol
; 13(6): 831-839, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29578107
11.
Impaired HLA Class I Antigen Processing and Presentation as a Mechanism of Acquired Resistance to Immune Checkpoint Inhibitors in Lung Cancer.
Cancer Discov
; 7(12): 1420-1435, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29025772
12.
Oncogenic EGFR Represses the TET1 DNA Demethylase to Induce Silencing of Tumor Suppressors in Cancer Cells.
Cell Rep
; 16(2): 457-471, 2016 07 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27346347
13.
Acquired resistance of EGFR-mutant lung adenocarcinomas to afatinib plus cetuximab is associated with activation of mTORC1.
Cell Rep
; 7(4): 999-1008, 2014 May 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-24813888
14.
Reduced NF1 expression confers resistance to EGFR inhibition in lung cancer.
Cancer Discov
; 4(5): 606-19, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24535670